IMPRS-IDI PhD Program 2025: The International Max Planck Research School for Infectious Diseases and Immunology (IMPRS-IDI) invites applications for its PhD recruitment call for 2025. This year, seven fully funded PhD positions are available for highly motivated candidates interested in a dynamic, interdisciplinary research environment focused on infectious disease and immunology.
Designation
Fully Funded PhD Positions
| Category | Details |
|---|---|
| Application Start Date | 15 November 2024 |
| Application Deadline | 3 January 2025, 23:59 CET |
| Number of Positions | 7 Fully Funded PhD Positions |
| Program Locations | Max Planck Institute for Infection Biology, |
| Charité-Universitätsmedizin Berlin, | |
| Technische Universität Berlin |
Research Area
- Infection Biology
- Immunology
- Microbiology
- Molecular & Cell Biology
- Parasitology
- Medical Biotechnology
- Quantitative Biology
- Epidemiology, Public Health & Mathematics
- Bioinformatics
- Biophysics
- Related disciplines in the life sciences
Location
Berlin, Germany
Eligibility/Qualification
- Highly motivated candidates from around the world
- Commitment to research in the specified disciplines
- Applicants should possess a relevant Master’s degree or equivalent
Description
The IMPRS-IDI is designed to develop creative, critical, responsible, and self-confident young researchers. The program offers state-of-the-art research and training opportunities, access to renowned faculty from prestigious institutions, and a project-adapted curriculum including training courses, lectures, seminars, and opportunities for traveling to present research work. The program promises a strong PhD community with international collaboration and lively engagement.
How to Apply
Interested candidates should apply through the IMPRS-IDI application platform starting from 15 November 2024. Ensure to check the project details and follow the application guidelines provided on the IMPRS-IDI website.
Last Date to Apply
3 January 2025, 23:59 CET
For further inquiries, please contact the IMPRS-IDI Office at: imprs-office@…
